BPC-157

BPC-157 (Body Protection Compound-157) at 10 mg provides a higher quantity for extended research protocols, dose-response studies, and long-duration tissue repair investigations. This pentadecapeptide has well-documented regenerative properties across multiple tissue types in preclinical models. Studies have demonstrated its ability to accelerate tendon healing by promoting type I collagen synthesis and fibroblast outgrowth, protect intestinal epithelium through tight junction protein upregulation, and promote angiogenesis through VEGF pathway modulation. BPC-157's mechanism of action involves interaction with the FAK-paxillin pathway, which is critical for cell adhesion and migration during wound healing. In inflammatory models, it has shown the ability to reduce TNF-α and IL-6 levels while promoting anti-inflammatory IL-10 expression. Research has also revealed BPC-157's potential to accelerate muscle healing following crush injuries and to promote bone healing through osteoblast stimulation. The 10 mg format supports multi-dose experimental designs and chronic administration protocols, making it ideal for researchers conducting longitudinal tissue repair studies.